Title |
Preclinical multimodality phantom design for quality assurance of tumor size measurement
|
---|---|
Published in |
BMC Medical Physics, September 2011
|
DOI | 10.1186/1756-6649-11-1 |
Pubmed ID | |
Authors |
Yongsook C Lee, Gary D Fullerton, Cristel Baiu, Margaret G Lescrenier, Beth A Goins |
Abstract |
Evaluation of changes in tumor size from images acquired by ultrasound (US), computed tomography (CT) or magnetic resonance imaging (MRI) is a common measure of cancer chemotherapy efficacy. Tumor size measurement based on either the World Health Organization (WHO) criteria or the Response Evaluation Criteria in Solid Tumors (RECIST) is the only imaging biomarker for anti-cancer drug testing presently approved by the United States Food and Drug Administration (FDA). The aim of this paper was to design and test a quality assurance phantom with the capability of monitoring tumor size changes with multiple preclinical imaging scanners (US, CT and MRI) in order to facilitate preclinical anti-cancer drug testing. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 26 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 5 | 19% |
Other | 4 | 15% |
Student > Master | 3 | 12% |
Student > Bachelor | 2 | 8% |
Professor | 2 | 8% |
Other | 4 | 15% |
Unknown | 6 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Engineering | 7 | 27% |
Medicine and Dentistry | 6 | 23% |
Physics and Astronomy | 4 | 15% |
Psychology | 2 | 8% |
Neuroscience | 1 | 4% |
Other | 1 | 4% |
Unknown | 5 | 19% |